Insider · CIK 0001423786

Sarena Francis Willard

Reports to the SEC for 5 companies · REDWOOD CITY, CA

sec.gov

Transactions

Companies

Filings

CIK

0001423786

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2025-10-30	ETNB89bio, Inc.U Disposition from Tender	Chief Operating Officer	UDisposition from Tender	−75.3K sh	—	—	0
2025-10-30	ETNB89bio, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Chief Operating Officer	DDisposition to Issuer	−350K sh	—	—	0
2025-10-30	ETNB89bio, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Chief Operating Officer	DDisposition to Issuer	−215K sh	—	—	0
2025-08-05	ETNB89bio, Inc.F Tax Payment	Chief Operating Officer	FTax Payment	−2,979 sh	$9.69	−$28.9K	74,231
2025-08-01	ETNB89bio, Inc.F Tax Payment	Chief Operating Officer	FTax Payment	−3,206 sh	$9.16	−$29.4K	77,210
2025-02-01	ETNB89bio, Inc.A Award	Chief Operating Officer	AAward	+53.8K sh	—	—	78,750
2025-02-01	ETNB89bio, Inc. · Stock Option (Right to Buy)A Award	Chief Operating Officer	AAward	+215K sh	—	—	215,000
2024-08-05	ETNB89bio, Inc.A Award	Chief Operating Officer	AAward	+25K sh	—	—	25,000
2024-08-05	ETNB89bio, Inc. · Stock Option (Right to Buy)A Award	Chief Operating Officer	AAward	+350K sh	—	—	350,000
2023-08-23	Apexigen, Inc.F Tax Payment	President and COO	FTax Payment	−31.1K sh	$0.39	−$12K	124,296
2023-08-23	Apexigen, Inc.D Disposition to Issuer	President and COO	DDisposition to Issuer	−124K sh	—	—	0
2023-08-23	Apexigen, Inc.Employee Stock Option (right to buy)D Disposition to Issuer	President and COO	DDisposition to Issuer	−270K sh	—	—	0
2023-06-15	Apexigen, Inc.F Tax Payment	President and COO	FTax Payment	−6,917 sh	$0.49	−$3,396.939	155,419
2023-05-23	Apexigen, Inc.A Award	President and COO	AAward	+150K sh	—	—	183,084
2023-05-23	Apexigen, Inc.F Tax Payment	President and COO	FTax Payment	−20.7K sh	$0.40	−$8,299.2	162,336
2022-12-15	Apexigen, Inc.F Tax Payment	President and COO	FTax Payment	−6,916 sh	$1.06	−$7,330.96	33,084
2022-10-07	Apexigen, Inc.A Award	President and COO	AAward	+40K sh	—	—	40,000
2021-04-16	FIVE PRIME THERAPEUTICS, INC.A Award	Chief Strategy Officer	AAward	+66K sh	—	—	169,468
2021-04-16	FIVE PRIME THERAPEUTICS, INC.D Disposition to Issuer	Chief Strategy Officer	DDisposition to Issuer	−169K sh	$38.00	−$6.44M	0
2021-04-16	FIVE PRIME THERAPEUTICS, INC.D Disposition to Issuer	Chief Strategy Officer	DDisposition to Issuer	−795 sh	$38.00	−$30.2K	0
2021-04-16	FIVE PRIME THERAPEUTICS, INC.D Disposition to Issuer	Chief Strategy Officer	DDisposition to Issuer	−795 sh	$38.00	−$30.2K	0
2021-04-16	FIVE PRIME THERAPEUTICS, INC.D Disposition to Issuer	Chief Strategy Officer	DDisposition to Issuer	−795 sh	$38.00	−$30.2K	0
2021-04-16	FIVE PRIME THERAPEUTICS, INC.Employee Stock Option (right to buy)D Disposition to Issuer	Chief Strategy Officer	DDisposition to Issuer	−4,747 sh	—	—	0
2021-04-16	FIVE PRIME THERAPEUTICS, INC.Employee Stock Option (right to buy)D Disposition to Issuer	Chief Strategy Officer	DDisposition to Issuer	−9,142 sh	—	—	0
2021-04-16	FIVE PRIME THERAPEUTICS, INC.Employee Stock Option (right to buy)D Disposition to Issuer	Chief Strategy Officer	DDisposition to Issuer	−12.1K sh	—	—	0
2021-04-16	FIVE PRIME THERAPEUTICS, INC.Employee Stock Option (right to buy)D Disposition to Issuer	Chief Strategy Officer	DDisposition to Issuer	−3,209 sh	—	—	0
2021-04-16	FIVE PRIME THERAPEUTICS, INC.Employee Stock Option (right to buy)D Disposition to Issuer	Chief Strategy Officer	DDisposition to Issuer	−25.5K sh	—	—	0
2021-04-16	FIVE PRIME THERAPEUTICS, INC.Employee Stock Option (right to buy)D Disposition to Issuer	Chief Strategy Officer	DDisposition to Issuer	−75K sh	—	—	0
2021-04-16	FIVE PRIME THERAPEUTICS, INC.Employee Stock Option (right to buy)D Disposition to Issuer	Chief Strategy Officer	DDisposition to Issuer	−45K sh	—	—	0
2021-04-16	FIVE PRIME THERAPEUTICS, INC.Employee Stock Option (right to buy)D Disposition to Issuer	Chief Strategy Officer	DDisposition to Issuer	−58K sh	—	—	0
2021-04-16	FIVE PRIME THERAPEUTICS, INC.Employee Stock Option (right to buy)D Disposition to Issuer	Chief Strategy Officer	DDisposition to Issuer	−90K sh	—	—	0
2021-04-16	FIVE PRIME THERAPEUTICS, INC.Employee Stock Option (right to buy)D Disposition to Issuer	Chief Strategy Officer	DDisposition to Issuer	−90K sh	—	—	0
2021-04-06	FIVE PRIME THERAPEUTICS, INC.G Gift	Chief Strategy Officer	GGift	−14.2K sh	—	—	103,468
2021-04-05	FIVE PRIME THERAPEUTICS, INC.G Gift	Chief Strategy Officer	GGift	−2,460 sh	—	—	117,642
2021-04-01	FIVE PRIME THERAPEUTICS, INC.G Gift	Chief Strategy Officer	GGift	−2,385 sh	—	—	121,542
2021-04-01	FIVE PRIME THERAPEUTICS, INC.G Gift	Chief Strategy Officer	GGift	+795 sh	—	—	795
2021-04-01	FIVE PRIME THERAPEUTICS, INC.G Gift	Chief Strategy Officer	GGift	+795 sh	—	—	795
2021-04-01	FIVE PRIME THERAPEUTICS, INC.G Gift	Chief Strategy Officer	GGift	+795 sh	—	—	795
2021-04-01	FIVE PRIME THERAPEUTICS, INC.G Gift	Chief Strategy Officer	GGift	−1,440 sh	—	—	120,102
2021-02-26	FIVE PRIME THERAPEUTICS, INC.F Tax Payment	Chief Strategy Officer	FTax Payment	−1,158 sh	$22.23	−$25.7K	123,433
2021-02-25	FIVE PRIME THERAPEUTICS, INC.F Tax Payment	Chief Strategy Officer	FTax Payment	−1,653 sh	$23.08	−$38.2K	124,591
2021-02-24	FIVE PRIME THERAPEUTICS, INC.F Tax Payment	Chief Strategy Officer	FTax Payment	−5,100 sh	$25.71	−$131K	126,244
2020-12-11	FIVE PRIME THERAPEUTICS, INC.M Exercise/Conversion	Chief Strategy Officer	MExercise/Conversion	+22K sh	—	—	138,010
2020-12-11	FIVE PRIME THERAPEUTICS, INC.F Tax Payment	Chief Strategy Officer	FTax Payment	−11.6K sh	$16.14	−$187K	126,427
2020-12-11	FIVE PRIME THERAPEUTICS, INC.Performance-Based Restricted Common StockM Exercise/Conversion	Chief Strategy Officer	MExercise/Conversion	−22K sh	—	—	0
2020-11-11	FIVE PRIME THERAPEUTICS, INC.M Exercise/Conversion	Chief Strategy Officer	MExercise/Conversion	+22K sh	—	—	127,011
2020-11-11	FIVE PRIME THERAPEUTICS, INC.F Tax Payment	Chief Strategy Officer	FTax Payment	−11K sh	$18.00	−$198K	116,010
2020-11-11	FIVE PRIME THERAPEUTICS, INC.Performance-Based Restricted Common StockM Exercise/Conversion	Chief Strategy Officer	MExercise/Conversion	−22K sh	—	—	22,000
2020-02-26	FIVE PRIME THERAPEUTICS, INC.F Tax Payment	Chief Strategy Officer	FTax Payment	−1,304 sh	$4.83	−$6,298.32	105,011
2020-02-25	FIVE PRIME THERAPEUTICS, INC.F Tax Payment	Chief Strategy Officer	FTax Payment	−1,863 sh	$4.87	−$9,072.81	106,315

Recent filings

Accepted (ET)
Oct 304
Sarena Francis Willard0001193125-25-259037
SEC(opens sec.gov)
Aug 54
Sarena Francis Willard0000950170-25-103380
SEC(opens sec.gov)
Feb 44
Sarena Francis Willard0000950170-25-014077
SEC(opens sec.gov)
Aug 74
Sarena Francis Willard0000950170-24-093069
SEC(opens sec.gov)
Aug 254
Sarena Francis Willard0001209191-23-047439
SEC(opens sec.gov)
Jun 234
Sarena Francis Willard0001209191-23-039495
SEC(opens sec.gov)
May 254
Sarena Francis Willard0001209191-23-032162
SEC(opens sec.gov)
Dec 194
Sarena Francis Willard0001209191-22-062004
SEC(opens sec.gov)
Oct 114
Sarena Francis Willard0001209191-22-053349
SEC(opens sec.gov)
Apr 194
Sarena Francis Willard0001209191-21-027427
SEC(opens sec.gov)

Companies

Address

1400 SEAPORT BLVD

REDWOOD CITY, CA, 94063